C1 Esterase Inhibition : Targeting Multiple Systems in COVID-19
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
---|---|
Enthalten in: |
Journal of clinical immunology - 41(2021), 4 vom: 20. Mai, Seite 729-732 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Adesanya, T M Ayodele [VerfasserIn] |
---|
Links: |
---|
Themen: |
Complement C1 Inhibitor Protein |
---|
Anmerkungen: |
Date Completed 04.05.2021 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s10875-021-00972-1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM320369730 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM320369730 | ||
003 | DE-627 | ||
005 | 20231225173427.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10875-021-00972-1 |2 doi | |
028 | 5 | 2 | |a pubmed24n1067.xml |
035 | |a (DE-627)NLM320369730 | ||
035 | |a (NLM)33474624 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Adesanya, T M Ayodele |e verfasserin |4 aut | |
245 | 1 | 0 | |a C1 Esterase Inhibition |b Targeting Multiple Systems in COVID-19 |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.05.2021 | ||
500 | |a Date Revised 07.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 4 | |a Review | |
650 | 7 | |a Complement C1 Inhibitor Protein |2 NLM | |
650 | 7 | |a Complement Inactivating Agents |2 NLM | |
650 | 7 | |a Complement C1s |2 NLM | |
650 | 7 | |a EC 3.4.21.42 |2 NLM | |
700 | 1 | |a Campbell, Courtney M |e verfasserin |4 aut | |
700 | 1 | |a Cheng, Lijun |e verfasserin |4 aut | |
700 | 1 | |a Ogbogu, Princess U |e verfasserin |4 aut | |
700 | 1 | |a Kahwash, Rami |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of clinical immunology |d 1981 |g 41(2021), 4 vom: 20. Mai, Seite 729-732 |w (DE-627)NLM012677426 |x 1573-2592 |7 nnns |
773 | 1 | 8 | |g volume:41 |g year:2021 |g number:4 |g day:20 |g month:05 |g pages:729-732 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10875-021-00972-1 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 41 |j 2021 |e 4 |b 20 |c 05 |h 729-732 |